BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8738153)

  • 1. Partial striatal dopamine depletion differentially affects striatal substance P and enkephalin messenger RNA expression.
    Nisenbaum LK; Crowley WR; Kitai ST
    Brain Res Mol Brain Res; 1996 Apr; 37(1-2):209-16. PubMed ID: 8738153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal dissociation between changes in striatal enkephalin and substance P messenger RNAs following striatal dopamine depletion.
    Nisenbaum LK; Kitai ST; Crowley WR; Gerfen CR
    Neuroscience; 1994 Jun; 60(4):927-37. PubMed ID: 7523989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic and muscarinic regulation of striatal enkephalin and substance P messenger RNAs following striatal dopamine denervation: effects of systemic and central administration of quinpirole and scopolamine.
    Nisenbaum LK; Kitai ST; Gerfen CR
    Neuroscience; 1994 Nov; 63(2):435-49. PubMed ID: 7534387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis.
    Gerfen CR; McGinty JF; Young WS
    J Neurosci; 1991 Apr; 11(4):1016-31. PubMed ID: 1707092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term changes in striatal opioid systems after 6-hydroxydopamine lesion of rat substantia nigra.
    Smith JA; Leslie FM; Broide RS; Loughlin SE
    Neuroscience; 1993 Aug; 55(4):935-51. PubMed ID: 8232904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DA uptake sites, D1 and D2 receptors, D2 and preproenkephalin mRNAs and Fos immunoreactivity in rat striatal subregions after partial dopaminergic degeneration.
    Chritin M; Blanchard V; Raisman-Vozari R; Feuerstein C; Agid Y; Javoy-Agid F; Savasta M
    Eur J Neurosci; 1996 Dec; 8(12):2511-20. PubMed ID: 8996800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide messenger RNA expression in the 6-hydroxydopamine-lesioned rat striatum reinnervated by fetal dopaminergic transplants: differential effects of the grafts on preproenkephalin, preprotachykinin and prodynorphin messenger RNA levels.
    Cenci MA; Campbell K; Björklund A
    Neuroscience; 1993 Nov; 57(2):275-96. PubMed ID: 8115038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin-2 receptor stimulation normalizes striatal preprotachykinin messenger RNA in an animal model of Parkinson's disease.
    Gresch PJ; Walker PD
    Neuroscience; 1999; 93(3):831-41. PubMed ID: 10473249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levodopa replacement therapy alters enzyme activities in striatum and neuropeptide content in striatal output regions of 6-hydroxydopamine lesioned rats.
    Engber TM; Susel Z; Kuo S; Gerfen CR; Chase TN
    Brain Res; 1991 Jun; 552(1):113-8. PubMed ID: 1717109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral dopamine depletion increases expression of the 2A subunit of the N-methyl-D-aspartate receptor in enkephalin-positive and enkephalin-negative neurons.
    Ganguly A; Keefe KA
    Neuroscience; 2001; 103(2):405-12. PubMed ID: 11246155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral 6-hydroxydopamine-induced lesion of the nigrostriatal dopamine pathway reproduces the effects of unilateral lesion on substance P but not on enkephalin expression in rat basal ganglia.
    Salin P; Hajji MD; Kerkerian-le Goff L
    Eur J Neurosci; 1996 Aug; 8(8):1746-57. PubMed ID: 8921265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-DOPA produces strong induction of c-fos messenger RNA in dopamine-denervated cortical and striatal areas of the common marmoset.
    Svenningsson P; Gunne L; Andren PE
    Neuroscience; 2000; 99(3):457-68. PubMed ID: 11029538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial dopamine loss enhances activated caspase-3 activity: differential outcomes in striatal projection systems.
    Ariano MA; Grissell AE; Littlejohn FC; Buchanan TM; Elsworth JD; Collier TJ; Steece-Collier K
    J Neurosci Res; 2005 Nov; 82(3):387-96. PubMed ID: 16180225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neonatal and adult 6-hydroxydopamine-induced lesions differentially alter tachykinin and enkephalin gene expression.
    Sivam SP; Breese GR; Krause JE; Napier TC; Mueller RA; Hong JS
    J Neurochem; 1987 Nov; 49(5):1623-33. PubMed ID: 2889804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic characterization of neurotensin messenger RNA-expressing cells in the neuroleptic-treated rat striatum: a detailed cellular co-expression study.
    Augood SJ; Westmore K; Emson PC
    Neuroscience; 1997 Feb; 76(3):763-74. PubMed ID: 9135049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of neonatal 6-hydroxydopamine injections on glutamate decarboxylase, preproenkephalin and dopamine D2 receptor mRNAs in the adult rat striatum.
    Soghomonian JJ
    Brain Res; 1993 Sep; 621(2):249-59. PubMed ID: 7902185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic intranigral administration of brain-derived neurotrophic factor produces striatal dopaminergic hypofunction in unlesioned adult rats and fails to attenuate the decline of striatal dopaminergic function following medial forebrain bundle transection.
    Lapchak PA; Beck KD; Araujo DM; Irwin I; Langston JW; Hefti F
    Neuroscience; 1993 Apr; 53(3):639-50. PubMed ID: 8098137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prefrontal corticostriatal afferents maintain increased enkephalin gene expression in the dopamine-denervated rat striatum.
    Campbell K; Björklund A
    Eur J Neurosci; 1994 Aug; 6(8):1371-83. PubMed ID: 7981878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic blockade of muscarinic cholinergic receptors by systemic trihexyphenidyl (Artane) administration modulates but does not mediate the dopaminergic regulation of striatal prepropeptide messenger RNA expression.
    Mavridis M; Rogard M; Besson MJ
    Neuroscience; 1995 May; 66(1):37-53. PubMed ID: 7637873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glial cell line-derived neurotrophic factor attenuates behavioural deficits and regulates nigrostriatal dopaminergic and peptidergic markers in 6-hydroxydopamine-lesioned adult rats: comparison of intraventricular and intranigral delivery.
    Lapchak PA; Miller PJ; Collins F; Jiao S
    Neuroscience; 1997 May; 78(1):61-72. PubMed ID: 9135089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.